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Overweight, obesity, and gestational diabetes (GD) during pregnancy may negatively affect
neurodevelopment in the offspring. However, the mechanisms are unclear and objective
measures of neurodevelopment in infancy are scarce. We hypothesized that these maternal
metabolic pathologies impair cortical visual evoked potentials (cVEPs), a proxy for visual
and neuronal maturity.
Design
The PREOBE study included 331 pregnant women stratified into four groups; normal weight
(controls), overweight, obesity, and GD (the latter including mothers with normal weight,
overweight and obesity). In a subsample of the offspring at 3 months (n = 157) and at 18
months (n = 136), we assessed the latencies and amplitudes of the P100 wave from cVEPs
and calculated visual acuity.
Results
At 3 months of age, visual acuity was significantly poorer in offspring born to GD mothers. At
18 months of age, there were no differences in visual acuity but infants born to GD mothers
had significantly longer latencies of cVEPs when measured at 15’, and 30’ of arc. The group
differences at 30’ remained significant after confounder adjustment (mean [SD] 121.0 [16.0]
vs. 112.6 [7.6] ms in controls, p = 0.007) and the most prolonged latencies were observed in
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Conclusions
Infants born to mothers with GD, particularly those with concurrent overweight or obesity,
have prolonged latencies of visual evoked potentials at 18 months of age, suggesting that
this maternal metabolic profile have a long lasting, non-optimal, effect on infants´ brain
development.
Introduction
The rates of overweigh and obesity have experienced exceptional growth and become an
increasing public health problem. Following this epidemic, numerous studies are currently
exploring how these metabolic pathologies affect human health.[1] One important research
field is the studies exploring the effect of overweight and obesity on pregnant women and their
offspring. It is known, that increased maternal weight before pregnancy, and rapid weight gain
during pregnancy, both constitute risk factors for development of gestational diabetes (GD)
and other gestational complications in the mother. [2] Furthermore, these conditions have
also been associated with impaired growth and neurodevelopment of the offspring, even at
long term. Early programmed adverse effects on body composition, metabolic, and mental
performance have been suggested.[3–12] However, these associations have been difficult to
confirm or reproduce, since precise and objective methodologies for neurodevelopment
assessment during infancy are scarce.
Measurement of cortical visual evoked potentials (cVEPs) is a neurophysiological technique
that can provide objective information about the function of the visual system in infants and
children too young to communicate visual symptoms or cooperate in the standard assessments
of visual function.[13] cVEPs have been suggested as a promising measure for the neurological
evaluation of visual function, and also a proxy for general neurodevelopment. The latencies of
the cVEP are closely correlated to the process of neuronal myelination that occurs during the
first 1–2 years of postnatal life.[14–16] Some studies have reported that infants born to moth-
ers with diabetes mellitus type I and type II have impaired latencies and amplitudes of cVEPs.
[17, 18] However, we found no previous studies exploring, the separated effect of overweight,
obesity and GD in patient without pre-gestational diabetes.
The objective of this study was to explore the cVEPs in offspring born to mothers with over-
weight, obesity and GD, and compare to children born to healthy normal weight controls. We
hypothesized that these maternal metabolic alterations would negatively affect the cVEPs in
the offspring at 3 and 18 month of age.
Methods
Study design and participants
The PREOBE study is a prospective mother-child cohort study, conducted between 2007 and
2012 (registered in www.ClinicalTrials.gov) with the purpose of studying the effects on preg-
nancies and offspring of PRE-gestational OBEsity, overweight and GD. The design of the
study has been published elsewhere.[19] In brief, 331 pregnant women with singleton preg-
nancies and age between 18 and 45 years were included between 12 to 20 weeks of pregnancy
(occasionally until 34 weeks). The mothers were stratified into four different groups based on
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their calculated pre-gestational body max index (BMI) and GD condition: Healthy normal
weight group (18.5 kg/m2BMI<25 kg/m2; n = 132), overweight group (25 kg/m2BMI<30
kg/m2; n = 56), obese group (BMI30 kg/m2; n = 64), and GD group (BMI18.5 kg/m2;
n = 79). The group allocation was performed at 34 weeks of gestation where all mothers with
GD diagnosed at any stage of pregnancy were allocated to the GD-group, independently of
BMI. Consequently, after such re-distribution, the GD included 23 with overweight, 24 with
obesity, and 32 with normal weight.
The exclusion criteria were: simultaneous participation in any other research study or any
of the following diseases; pre-gestational diabetes, hypertension or preeclampsia, fetal intra-
uterine growth retardation, maternal infection during pregnancy, hypo/hyperthyroidism,
hepatic diseases and renal disease), and vegan diet. In the present analyses, another 2 cases
were excluded after delivery due to congenital disorder in the offspring (Fig 1).
Ethical statement
The research was approved by the Bioethical Committees for Clinical Research of the Clinical
University Hospital San Cecilio and the Mother-Infant University Hospital of Granada. An
Fig 1. Study profile. 1 Of the 331 included mothers, 21 dropped out of the study before delivery and another 73 before the first neurodevelopmental follow up
at 3 months of age. 2 Two mother-child pairs were excluded after delivery due to congenital disorders. 3 Seventeen mother–child pairs at 3 months and six at 6
months did not show up at the assessments but remained in the study for later visits, those are described as “not attending”.
https://doi.org/10.1371/journal.pone.0203754.g001
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ethical approval was also obtained by the Research Bioethical Committee of the University of
Granada. Written informed consent was obtained from all mothers and/or tutors at their off-
spring follow-up study entry.
Data collection
As a part of the original study design, information regarding maternal age, pre-gestational
weight, maternal educational level, parity, smoking habits during pregnancy, marital status
and maternal intelligence quotient (IQ) were obtained at inclusion and all mothers were
assessed at 24, at 34 weeks, and at delivery, including measures of iron status and glucose. We
also registered information regarding the newborn child, including gestational age, sex,
anthropometrics and cord blood laboratory status.[19]
In the present neurodevelopmental follow up study, the mother–infant pairs were called
back for follow-up visits at 3, 6 and 18 months of age including cVEPs (3 and 18 months),
neuropsychological testing (6 and 18 months), anthropometric measures and health question-
naires. The three preterm babies were assessed at corrected age.
Cortical visual evoked potentials
At 3 months of age we were able to evaluate cVEPs in 157 infants (Fig 1). Apart from the two
excluded cases (congenital disorder), 73 participants dropped out after delivery, 17 infants
remained in the study but their parents decided not to participate the follow up at 3 months,
and 61 cases came to the evaluation but the cVEP measure failed because the child could not
be calmed. In one of the cases at 3 months, we only registered latencies and in another one
only the amplitudes, resulting in 156 cases analyzed for each outcome. Moreover, at 18 months
of age, another 38 had dropped out and successful measures of cVEP were performed in 136 of
the 197 infants assessed (S1 Table). The reasons for drop out during the follow up period
between delivery and 18 months was not monitored in detail and most drop outs did not
declare their reasons.
Infants’ cVEPs were recorded in a partially darkened room (mean background light 0.15 ft-
Lamberts; dark adaptation for 20 minutes) in awake condition (without sedation). Two caps of
two different sizes (38–42 cm at six months and 42–46 cm at eighteen months) with electrodes
placed according to the 10–20 system were used (Electro-Cap International including: Fz as ref-
erence, O1, Oz and O2 as actives [Oz on inion, O1 3cm on the left and O2 3 cm on the right]
and Cz as ground electrode). [20] cVEPs were obtained in a quiet room under controlled con-
ditions while the participants were aware, alert and placed at the same height as the stimulation
screen. If the baby did not keep attention, then the test stopped and only began when attention
came back. The cVEPs in infants were registered using a Schwarzer topas EMG System,
(NATUS, California, USA). The visual stimulus was a reversal pattern of black and white
checkerboard (contrast 100%) generated on a CRT monitor. Stimulus were performed in a
shape of binocular frequencies at 2˚, 1˚, 30 ’, 15’ and 7½’. The average luminance was 39 kcd/
m2 and the investment rate was 2.1. Responses were amplified with filter from 1.5 Hz to 100
Hz. As outcome in the present paper we used the P100 wave latencies and amplitudes as sug-
gested by McCulloch and Skarf.[13] Visual acuity was calculated using linear regression
between amplitudes and visual angle (transformed to cycles per minutes).[21] Only cases with
a regression coefficient above 0.5 were included in the analyses.
Neurodevelopmental testing
At 6 and 18 months of age, infants’ neurodevelopment were assessed by using the Bayley Scales
of Infant Development, Third Edition (BSID-III). All infants were examined by the same
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trained psychologist (FJTE). The infant evaluation by BSID-III is performed across five
domains: cognitive skills, receptive language, expressive language, fine motor, and gross motor
development and a parental questionnaire to evaluate socioemotional development. [22]
Statistical method
All statistical analyses were performed using the SPSS statistical software package for Windows
(version 22.0; IBM SPSS Inc., Chicago, IL, USA). Continuous and normally distributed vari-
ables were displayed as mean and standard deviation (SD). Differences between the four
groups in cVEP were explored using unadjusted analysis of variance (ANOVA) as well as con-
founder adjusted analyses using multivariate analyses of covariance (ANCOVA). The con-
founder introduced in the models were gestational age at birth and sex, due to a significant
correlation to at least one cVEP outcome and maternal age and maternal education due to sig-
nificant group differences. The significance level was set to p<0.05. This study was originally
powered based on outcomes during pregnancy.[19]
Results
Table 1 shows the background and baseline characteristics of the mothers and their offspring
in all 157 infants evaluated at 3 months, including comparison of these characteristics between
groups. We observed significant differences between the study groups in maternal age and
there was a non-significant trend of higher educational levels in the control group and in the
overweight group compared to the other two. Three cases were born preterm, one born to an
obese, one to an overweight, and one born to diabetic mother. No severe complications such
as asphyxia were recorded in the analyzed infants.
The results of the cVEPs performed at 3 and 18 months, including a comparison between
the four PREOBE-groups are presented in Table 2. At 18 months of age, there were significant
group differences in the latencies of P100 at 1˚ (p = 0.033) and at 30’ of arc (p = 0.003). A simi-
lar trend was observed at 15’ (p = 0.053) and 7½’ of arc (p = 0.059). The post hoc analyses dem-
onstrated significantly prolonged latencies in children born to GD mothers compared to those
of normal weight mothers in the waves P100 at 30’ of arc (Bonferroni adjusted p-value for
infants born to GD vs. normal weight = 0.002) and P100 at 15’ of arc (Bonferroni adjusted p-
value = 0.042). In confounder adjusted analyses (Pb-value in Table 2), the overall group differ-
ences remained significant with regard to the latencies obtained at 30’ of arc (p-value for
ANOVA = 0.007) and the post hoc test for difference between GD-group and controls. Fur-
thermore, a similar significant group difference in the adjusted model was found regarding the
latencies of P100 at 7½’ of arc (p-value for ANCOVA = 0.044).
To further explore the differences observed in latencies of P100 at 30’ of arc at 18 months of
age between infants from the GD group and those from normal weight group, we stratified the
diabetic group based on the maternal pre-gestational BMI. Each subgroup of infants born to
GD mothers (normal weight, overweight and obese) was compared to the control group with
mean (SD) of 112.6 (7.6) ms. We found, in confounder adjusted analyses, the most prolonged
latencies in those babies born to overweight (128.9 (26.9) ms, p = 0.002 vs. controls) and obese
(118.5 (5.1) ms, p = 0.020) diabetic mothers, while the normal weight diabetic group did not
differ significantly (116.6 (6.1) ms, p = 0.140).
Visual acuity could only be assessed in a subsample of the study (Table 3). For those, there
was a significant group difference in visual acuity at 3 months of age (p = 0.014). The post hoc
test showed that the vision was significantly lower in infants born to GD mothers compared to
controls with a logMAR mean difference of 0.19 (95% CI: 0.07–0.31). At 18 months, there
were no differences in visual acuity.
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In secondary analyses we used linear regression to assess the relationship between dichoto-
mized cVEP measures (using a median [P50] or third quartile split [P75]), and the 3 main
scores of the Bayley III test at 18 months (language, motor function and cognitive function). All
analyses were adjusted for gestational age and infant sex. The regression models revealed sig-
nificant correlations to composite cognitive scores at 18 months: latencies of wave P100 at 30’
of arc above P75 measured in infants at 3 months of age, correlated significantly to lower cog-
nitive composite score at 18 months (adjusted, unstandardized regression coefficient R [95%
CI]: -4.5 [-9.00; -0.069], p = 0.047); and, at 18 months of life, amplitudes of wave P100 at 30’ of
arc above P50 correlated significantly to higher cognitive scores (adjusted, unstandardized
regression coefficient R [95% CI]: 3.915 [0.209; 7.620], p = 0.039). No correlations were
observed between cVEPs and motor or language scores.
Discussion
In this study, we explored the influence of being born to a mother with overweight, obesity or
GD during pregnancy on the brain development using cVEPs as a proxy. While there were no
Table 1. Baseline and background characteristics of the mother-child pairs who participated in the cVEPs follow up at 3 months of age (n = 157), including group
comparisons among the four PREOBE-groups.
Normal weight Overweight Obese Gestational Diabetes p
n = 51 n = 27 n = 30 n = 49
Maternal Glucose at 24 weeks (mg/dl) 80.64±19.16 91.54±16.03 88.08±17.13 101.31±27.83 0.004
Maternal Glucose at 34 weeks (mg/dl) 86.21±20.41 89.65±21.28 91.93±17.27 95.01±23.93 0.278
Maternal Glucose at delivery (mg/dl) 80.09±20.04 91.50±24.37 95.85±34.06 98.24±34.23 0.028
Maternal Ferritin at 24 weeks (ng/ml) 23.05±17.25 19.71±12.25 33.73±27.10 25.39±17.83 0.061
Maternal Ferritin at 34 weeks (ng/ml) 18.04±15.37 13.50±7.13 16.04±8.66 21.24±16.47 0.109
Maternal Ferritin at delivery (ng/ml) 27.56±16.12 26.28±17.55 17.05±6.92 31.23±16.08 0.014
Maternal Age (y) 31±7 33±4 30.50±8 34±6 <0.001
Maternal educational level Primary/Secondary 44.9% 55.6% 73.3% 65.3% 0.058
University/Doctor 55.1% 44.4% 26.7% 34.7%
Marital Status Single/Separated 2% 0% 6.7% 0% 0.291
Married/Cohabitating 95.9% 100% 90% 100%
Others 2% 0% 3.3% 0%
Maternal IQ (points) 111±15 104±21 106±22 104±20 0.177
No of siblings 0 59.2% 59.3% 40.3% 55.1% 0.534
1 40.8% 40.3% 56.7% 44.9%
Smoking no 83.7% 87% 96% 93% 0.335
yes 16.3% 13% 4% 7%
Birth weight (g) 3277±398 3353±482 3468±541 3278±407 0.253
Birth HC (cm) 34.61±1.39 34.6±1.21 34.50±1.64 34.63±1.35 0.987
Gestational Age at birth (wk) 40±1 39±3 40±6 39±5 0.569
Cord Blood Glucose (mg/dl) 68.77±20.90 64.00±19.42 70.16±26.40 73.61±20.85 0.468
Cord Blood Ferritin (ng/ml) 182.41±103.99 177.30±97.45 187.72±90.28 181.26±112.46 0.994
Sex Boy 46.9% 40.7% 60.7% 55.1% 0.416
Girl 53.1% 59.3% 39.3% 44.9%
Infant type of feeding Breast-fed 57.1% 53.8% 37.9% 42.6% 0.426
Infant formula 18.4% 19.2% 13.8% 19.1%
Mixed 24.5% 26.9% 48.3% 38.3%
Data are mean ± Standard Deviation and p-values for unadjusted overall group effect using ANOVA for means and Chi-square test for proportions.
Values significantly different from the normal weight group in a Bonferroni adjusted post hoc test. HC: head circumference.
https://doi.org/10.1371/journal.pone.0203754.t001
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significant differences in latencies and amplitudes obtained in the offspring of non-diabetic
overweight or obese women compared to controls, children born to mothers with GD had sig-
nificantly poorer visual acuity at 3 months and prolonged latencies of cVEPs at 18 months of
age. The difference was most pronounced in the subgroups of gestational diabetic mothers
who were also overweight or obese, suggesting a negative interaction of these two risk factors.
In a secondary analysis we observed that short latencies at 3 months and high amplitudes at 18
Table 2. Amplitudes and latencies of infant’s P100 visual evoked potentials (cVEPs) at 3 and 18 months of age in children born to mothers with pre-pregnancy over-
weight, obesity or gestational diabetes compared to those born to healthy normal weight pregnant women (controls).
Normal Weight Overweight Obesity Gestational Diabetes pa pb
Latencies at 3 mo (ms) n = 51 n = 27 n = 30 n = 49
P100–2 of arc 115.01±13.94 112.57±8.52 117.66±12.85 117.81±13.71 0.316 0.648
P100–1 of arc 119.55±15.10 117.86±10.32 121.08±13.04 123.09±14.80 0.403 0.799
P100–30’ of arc 125.99±15.18 124.39±15.00 129.13±17.27 130.70±16.69 0.305 0.660
P100–15’ of arc 136.72±19.05 136.36±15.27 140.40±17.89 143.12±15.76 0.272 0.685
P100–7 ½’ of arc 147.70±21.18 145.91±13.43 147.75±16.26 154.67±15.63 0.481 0.811
Amplitudes at 3 mo (Hz)
P100–2 of arc 21.19±12.01 22.77±11.69 23.64±17.79 26.92±13.90 0.246 0.224
P100–1 of arc 21.95±11.16 21.66±10.02 21.58±15.29 24.94±13.88 0.554 0.511
P100–30’ of arc 18.14±9.34 18.15±8.74 16.53±11.32 21.09±11.56 0.254 0.326
P100–15’ of arc 15.16±8.98 15.56±7.06 14.50±8.65 15.63±8.09 0.958 0.834
P100–7 ½’ of arc 8.30±6.22 9.37±6.18 13.60±10.18 9.86±6.39 0.182 0.116
Latencies at 18 mo (ms) n = 47 n = 31 n = 22 n = 36
P100–2 of arc 106.24±5.76 105.80±7.65 108.08±13.96 109.77±11.26 0.316 0.340
P100–1 of arc 108.66±6.79 109.00±7.20 108.31±6.09 113.10±9.54 0.033 0.079
P100–30’ of arc 112.57±7.64 114.71±7.79 113.69±6.00 120.98±16.03 0.003 0.007
P100–15’ of arc 119.17±9.11 120.51±13.27 121.67±9.11 126.28±12.82 0.053 0.088
P100–7 ½’ of arc 127.09±9.52 132.68±10.98 126.91±11.70 132.37±5.27 0.059 0.044
Amplitudes at 18 mo (Hz)
P100–2 of arc 22.49±12.43 20.11±10.61 19.63±10.37 21.22±13.08 0.776 0.949
P100–1 of arc 24.56±12.62 21.78±12.53 22.70±13.43 23.49±15.31 0.838 0.892
P100–30’ of arc 21.77±10.60 19.90±12.80 18.24±11.16 20.17±12.58 0.704 0.850
P100–15’ of arc 19.83±10.28 18.93±10.66 15.66±11.93 19.75±12.21 0.534 0.592
P100–7 ½’ of arc 19.09±9.36 15.88±9.70 16.90±11.92 16.35±6.85 0.535 0.696
Data are mean ± Standard Deviation, pa-values for unadjusted overall group effect using ANOVA, and pb-values for overall group difference adjusted for gestational age
at birth, maternal age, infant sex and maternal education using ANCOVA.
Values significantly different from the normal weight group in a Bonferroni adjusted post hoc test.
https://doi.org/10.1371/journal.pone.0203754.t002
Table 3. Estimated visual acuity at 3 and 18 months of age in children born to mothers with pre-pregnancy overweight, obesity or gestational diabetes compared to
those born to healthy normal weight pregnant women (controls).
Normal weight Overweight Obesity Gestational Diabetes p
n = 33 n = 12 n = 13 n = 29
Visual Acuity at 3 mo (logMAR) 1.03±0.28 1.09±0.17 1.16±0.19 1.22±0.20 0.014
n = 21 n = 15 n = 10 n = 15
Visual Acuity at 18 mo (logMAR) 0.94±0.25 0.96±0.23 0.99±0.19 1.04±0.24 0.618
Data are mean ± Standard Deviation and p-values for overall group effect using ANOVA.
Values significantly different from the normal weight group in a Bonferroni adjusted post hoc test.
https://doi.org/10.1371/journal.pone.0203754.t003
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months significantly correlated to higher Bayley III scores of cognition, supporting the clinical
relevance of cVEPs in assessing infant development.
Maternal diabetes and obesity are common example of early risk factors that may contrib-
ute to “early programming” of later health and disease as suggested by Barker. [23] These con-
ditions have been associated with poor neurodevelopment in several previous studies, even
though the mechanisms are unclear and causality is not yet shown.[17, 24–27] BeBoer et al.
[28] showed that offspring born to pregnant women with type I diabetes showed lower Bayley
II scores of motor- and cognitive development at 12 months of age. Ornoy et al. [29, 30] found
that children born to GD mothers had lower cognitive, gross motor and fine motor develop-
ment scores at 9 years of age; even more, they reported that they were more likely to develop
disorders of attention such as hyperactivity and impulsivity (ADHD). In the Avon Longitudi-
nal Study of Parents and Children (ALSPAC), Fraser et al. [31] concluded that GD is consis-
tently associated with lower cognitive development (a difference up to 5 points in IQ) and low
educational levels among the offspring. They also concluded that the exact mechanism behind
the association between diabetes and poor neurodevelopment is unclear. The suboptimal met-
abolic control during GD has been suggested to cause dysfunctions at the cortical level in the
brain; this hypothesis is partly supported by previous studies carried out in humans and ani-
mals.[32–36] Our results suggest a mechanism that includes impaired neuronal function, since
cVEPs are considered a proxy for neuron myelination (latencies) and visual acuity (ampli-
tudes),[37, 38] and are in agreement with studies reported by Brinciotti et al.[18, 39]
If the observation found in this study represents a true causal relationship, it suggests that
the hyperglycemic status of GD mothers, have contributed to the observed effects in the off-
spring, either directly during fetal life or by affecting their postnatal precondition. Since this is
an observational study, we can only speculate regarding such mechanisms: During the prenatal
phase, the hyperglycemic status of the GD mothers is transferred to the fetus. This was also
found in the present cohort where cord blood glucose levels were higher in the offspring to
GD mothers compared to the other groups.[19] It has been shown that the fetal pancreas
already at 20 weeks of gestational age is capable to respond to this hyperglycemia by increasing
insulin secretion and increase the fetal metabolism with up to 30%. Again, this was also likely
in the present cohort where cord blood insulin levels were higher in the GM group, even
though the differences did not reach statistical significance.[19] It is likely that this state of
hyperglycemia, hyperinsulinemia and enhanced metabolism, may have lay ground for a poorer
myelination process of the auditory system. For instance, an increased metabolism has been
associated with increased risk of fetal hypoxia that follow due to limited oxygen transport
through the placenta.[4, 40] With regard to postnatal mechanisms, GD increases the risk of
hypoglycemia in the newborn offspring, a condition that has been associated with impaired
neurodevelopment in previous studies and may also explain an impaired visual development.
[41] Unfortunately, we did not monitor postnatal glucose levels in the infants and such mecha-
nism cannot be further explored in the present dataset. Another possible mechanism behind
the impaired cVEPs is iron deficiency. It has been well shown that infants born to diabetic
mothers are at increased risk of iron deficiency,[42] which is correlated to impaired neurode-
velopment. In a subsample of the present cohort, we measured iron status in cord blood and
found no lower iron stores in infant born to the GD mothers.[19] Finally, it has been suggested
that infants born to diabetic mothers are at high risk of hypomagnesemia.[43] Magnesium
plays an important role in a wide variety of critical cellular processes including carbohydrate
metabolism. Magnesium depletion, particularly in the hippocampus, has been associated to
impaired cognitive development and cerebral palsy.[44] Unfortunately, maternal or infant
magnesium was not assessed in the present study and we could not analyze its impact on the
results.
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An interesting observation was that the differences in latencies, most likely correlating to
the degree of neuronal myelination, was not significant at 3 months but at 18 months. Neuro-
nal myelination is an ongoing process during the first two years of life and the results suggests
that the negative effect that follows GD has a negative impact on the myelination, also during
the postnatal brain development. However, the non-significant effect at 3 months may also
correlate to difficulties of assessing this outcome at such a low age.
The correlations observed between cVEPs and cognitive scores are similar to previous stud-
ies. Nelson et al. reported that cVEPs technique correlated to memory deficits in children.[35]
We have previously reported no significant differences in Bayley scores in the infants born to
GD mothers, but a trend of lower scores in the obese group at 18 months.[27] The cVEPs con-
stitute a more objective outcome with regard to neuron function and myelination, however, it
will require further long term follow-up trials to explore if cVEPs or Bayley scores in early life
are good predictors of long term cognitive development.
Due to its observational design, this study was limited with regard to exploring causative
correlations. Furthermore, it was limited by the large drop outs between delivery and 6 months
of age. However, we used an objective neurophysiological test in a large number of participants
and adjusted for several important sociodemographic confounders, making our observed cor-
relations relevant for the research field. Furthermore, the study was strengthened by the fact
that we could separately analyze the correlation to gestational diabetes and overweight, and
obesity respectively. Nevertheless, the observation about poor cVEPs in GD mothers’ offspring
requires confirmative and larger studies. Furthermore, it is relevant to further explore the
interaction with maternal overweight and obesity.
In conclusion, infants born to mothers with GD had less developed cVEPs at 18 months,
suggesting a suboptimal neurodevelopment. We hypothesize that the mechanism behind this
observation is a poor maternal metabolic control causing damage to the developing brain in
the fetus. Furthermore, our results suggest a negative interaction with maternal obesity/over-
weight indicating that the double burden of high pre-gestational BMI and GD causes increased
risk. Moreover, cVEPs measures correlated to the Bayley scores at 18 months of age, support-
ing the hypothesis that cVEPs are promising a proxy for cognitive development in infancy.
Supporting information
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